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QSARAbstract A series of gallic acid derivatives (1–33) was synthesized and characterized by physico-
chemical and spectral means. The synthesized compounds were evaluated in vitro for their antimi-
crobial activity against different Gram positive and Gram negative bacterial and fungal strains by
the tube dilution method. Results of antimicrobial screening indicated that compound 6 was the
most active antimicrobial agent (pMICam = 1.92 lM/mL). The results of QSAR studies demon-
strated that antibacterial, antifungal and overall antimicrobial activities of synthesized gallic acid
derivatives were governed by the electronic parameters, cosmic total energy (Cos E.) and nuclear
energy (Nu. E.).
ª 2013 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
After the discovery of penicillin by Alexander Fleming, antibi-
otics were regarded as wonder drugs for curing virtually all
infections. However, the careless use and overconsumption
of antibiotics in both human and veterinary medicine have
led to the emergence of antibiotic-resistant bacterial strains.
Of major concern is the development of antibiotic resistance
in Staphylococcus aureus, primarily because S. aureus is fre-
quently associated with hospital and community-acquired
infections. Infections with multi-drug resistant S. aureus have
become responsible for huge healthcare costs and are projected
to be responsible for more deaths this year in the United Statesthan HIV/AIDS. Despite this increasing problem of antibiotic
resistance, the number of different antibiotics available is
dwindling and there are only a handful of new antibiotics in
the drug development pipeline. Therefore, there is an urgent
need for new antibacterial drugs preferably with new modes
of action to potentially avoid cross-resistance (Jang et al.,
2011).
The antimicrobial potential of simple organic acids is well
established in the literature viz. sorbic acid (Narasimhan
et al., 2003), cinnamic acid (Narasimhan et al., 2004), anacar-
dic acid (Narasimhan and Dhake, 2006a), veratric acid
(Narasimhan et al., 2009), myristic acid (Narasimhan et al.,
2006b), caprylic acid (Chaudhary et al., 2008), anthranilic acid
(Mahiwal et al., 2012) and dodecanoic acid (Sarova et al.,
2011). The literature reports reveal that the gallic acid and
its derivatives possess wide spectrum of biological activities
like antimicrobial (Chanwitheesuk et al., 2007), anticancer
(Saxena et al., 2008), antiviral (Thapa et al., 2012), anti-inﬂam-
matory (Arunkumar et al., 2009), analgesic (Krogh et al.,
2000) and anti-HIV activities (Kratz et al., 2008).rabian
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tural basis of biological activity. The success of QSAR
approach can be explained by the insight offered into the struc-
tural determination of chemical properties and the possibility
to estimate the properties of new chemical compounds without
the need to synthesize and test them (Sawant et al., 2012).
In light of abovementioned facts and in continuation of our
research efforts in the ﬁeld of synthesis, antimicrobial evalua-
tion and QSAR studies (Sigroha et al., 2012; Kumar et al.,
2010, 2012; Judge et al., 2012a,b; Narang et al., 2012a,b), we
hereby report the synthesis, antimicrobial evaluation and
QSAR studies of gallic acid derivatives.
2. Material and methods
All reagents and solvents used in the study were of analytical
grade and procured locally. The progress of the reaction was
monitored by TLC and products were puriﬁed through recrys-
tallization and purity of the compounds was checked by thin
layer chromatography (TLC) performed on silica gel G coated
plate. The spectral studies, IR and 1H NMR were determined
by standard methods. Infra red (IR) spectra were recorded on
FTIR Bruker ATR instrument and was recorded in cm1. The
1HNMR spectra were recorded in DMSO-d6 on a Bruker
DRX-300 FTNMR instrument. Elemental analysis was per-
formed on a Perkin–Elmer 2400 C, H, N analyzer.
2.1. General procedure for the synthesis of 3,4,5-
trihydroxybenzoyl chloride
Thionyl chloride (0.3 mol) was added gradually to gallic acid
(0.25 mol) in a round bottom ﬂask. After addition of thionyl
chloride, the mixture was stirred for 4 h and heated to 80 C
for 30 min in water bath. The excess of thionyl chloride was
removed by distillation.
2.2. General procedure for the synthesis of amides/anilides of
gallic acid
The solution of corresponding amine/aniline (0.1 mol) in ether
(50 mL) was added dropwise to a solution of 3,4,5-tri-
hydroxybenzoyl chloride (0.1 mol, synthesized in previous
step) in ether (50 mL) maintained at 0–10 C (Scheme 1).
The solution was stirred for 30 min and the precipitated
amide/anilide was separated by ﬁltration. The crude amide
was recrystallized with alcohol. In case of anilides, the precip-
itated crude anilide was treated with 5% hydrochloric acid,
4% sodium carbonate and water to remove residual aniline
and the resultant anilide was recrystallized with alcohol.
2.3. General procedure for the synthesis of esters of gallic acid
(3–6, 10, 19, 23, 24, 26 and 32)
A solution of different alcohols in ether (50 mL) was added to
a solution of 3,4,5-trihydroxybenzoyl chloride (0.05 mol) in
ether (50 mL). The mixture was heated on a water bath until
no further evolution of hydrogen chloride was observed. The
mixture was cooled to room temperature and evaporation of
solvent yielded the crude ester which was puriﬁed by recrystal-
lization with alcohol.Please cite this article in press as: Khatkar, A. et al., Synthesis, antimicro
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2013.11.012.4. General procedure for the synthesis of esters of gallic acid (2
and 12)
A mixture of gallic acid (0.08 mol) and appropriate alcohol
(0.74 mol) was heated under reﬂux in the presence of sulfuric
acid (Scheme 1) till the completion of reaction. Then, the reac-
tion mixture was poured in 200 mL ice cold water, neutralized
with sodium bicarbonate solution followed by extraction of
ester with ether (50 mL). The ether layer was separated, which
on evaporation yielded the esters of gallic acid.
2.4.1. Compound 1
IR (ATR) cm1: 1190 and 1457 (CAO str. and OAH in plane
bending, phenol), 1624 (C‚O str., 20 amide), 3071 (CAH str.,
aromatic), 1558 (C‚C skeletal str., phenyl), 771 (CACl str.,
C6H4Cl);
1H NMR (DMSO-d6): d 6.63–7.51 (m, 6H, aro-
matic), 8.69 (s, 1H, NH of amide); Anal. Calculated for C13-
H10ClNO4: C, 55.83; H, 3.60; N, 5.01; Found: C, 55.81; H,
3.63; N, 5.00.
2.4.2. Compound 3
IR (ATR) cm1: 3618 (OAH str., phenol), 1709 (C‚O str.,
ester), 3074 (CAH str., aromatic), 1545 (C‚C skeletal str.,
phenyl), 1337 (NO2 sym. str., ArANO2);
1H NMR (DMSO-
d6): d 6.91–8.13 (m, 6H, aromatic); Anal. Calculated for
C13H9NO7: C, 53.62; H, 3.12; N, 4.81; Found: C, 53.65; H,
3.10; N, 4.85.
2.4.3. Compound 5
IR (ATR) cm1: 3609 (OAH str., phenol), 1741 (C‚O str.,
ester), 1464 (CH2 scissoring, cyclohexane), 1022 (ring str.,
cyclohexane), 3074 (CAH str., aromatic), 1544 (C‚C skeletal
str., phenyl); 1H NMR (DMSO-d6): d 6.72–6.92 (m, 2H, aro-
matic), 1.13–1.73 (m, 10H, cyclohexane), 3.59 (m, 1H, a to
AOAC‚O); Anal. Calculated for C13H16O5: C, 61.90; H,
6.39; Found: C, 61.94; H, 6.37.
2.4.4. Compound 6
IR (ATR) cm1: 3621 (OAH str., phenol), 1740 (C‚O str.,
ester), 3067 (CAH str., aromatic), 1546 (C‚C skeletal str.,
phenyl), 1395 (ring str., quinoline), 745 (CAH out of plane
bending, quinoline), 1626 (C‚N str., quinoline); 1H NMR
(DMSO-d6): d 7.54–7.55 (m, 2H, aromatic), 7.72–8.03 (m,
6H, CH2); Anal. Calculated for C16H11NO5: C, 64.65; H,
3.73; N, 4.71; Found: 64.67; H, 3.71; N, 4.74.
2.4.5. Compound 7
IR (ATR) cm1: 3619 (OAH str., phenol), 1648 (C‚O str.,
20 amide), 3027 (CAH str., aromatic), 1548 (C‚C skeletal
str., phenyl), 2932 (CAH str., alkane); 1H NMR (DMSO-
d6): d 7.10–7.14 (m, 2H, aromatic), 2.31–3.39 (m, 13H, ali-
phatic), 8.22 (s, 1H, NH of amide); Anal. Calculated for
C13H19NO4: C, 61.64; H, 7.56; N, 5.53; Found: C, 61.68;
H, 7.53; N, 5.51.
2.4.6. Compound 14
IR (ATR) cm1: 1181 and 1443 (CAO str. and OAH in plane
bending, phenol), 1630 (C‚O str., 20 amide), 3066 (CAH str.,
aromatic), 1587 (C‚C skeletal str., phenyl), 1310 (NO2 sym.
str., ArANO2), 2838 (CH3 str., ArACH3);
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Scheme 1 Scheme for the synthesis of gallic acid derivatives.
Synthesis, antimicrobial evaluation and QSAR studies of gallic acid derivatives 3(DMSO-d6): d 7.13–7.44 (m, 5H, aromatic), 2.34 (s, 3H, CH3);
Anal. Calculated for C14H12N2O6: C, 55.27; H, 3.98; N, 9.21;
Found: C, 55.30; H, 4.00; N, 9.22.
2.4.7. Compound 22
IR (ATR) cm1: 3605 (OAH str., phenol), 1761 (C‚O str.,
ester), 3092 (CAH str., aromatic), 1513 (C‚C skeletal str.,
phenyl), 2912 (CAH str., alkane); 1H NMR (DMSO-d6): d
6.91 (m, 2H, aromatic), 4.29 (m, 2H, CH2), 2.08 (t, 3H,
CH3); Anal. Calculated for C9H10O5: C, 54.55; H, 5.09;
Found: C, 54.59; H, 5.06.
2.4.8. Compound 27
IR (ATR) cm1: 1254 and 1432 (CAO str. and OAH in plane
bending, phenol), 1624 (C‚O str., 20 amide), 3070 (C‚H str.,
aromatic), 1572 (C‚C skeletal str., phenyl), 1344 (NO2 sym.
str., Ar‚NO2);
1H NMR (DMSO-d6): d 6.58–7.41 (m, 6H,
aromatic), 7.96 (s, 1H, NH of amide); Anal. Calculated forPlease cite this article in press as: Khatkar, A. et al., Synthesis, antimicro
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2013.11.01C13H10N2O6: C, 53.80; H, 3.47; N, 9.65; Found: C, 53.83; H,
3.51; N, 9.62.
2.4.9. Compound 28
IR (ATR) cm1: 1255 and 1436 (CAO str. and OAH in plane
bending, phenol), 1626 (C‚O str., 20 amide), 3065 (CAH str.,
aromatic), 1545 (C‚C skeletal str., phenyl), 746 (CACl str.,
C6H3Cl);
1H NMR (DMSO-d6): d 6.21–7.34 (m, 5H, aro-
matic), 7.50 (s, 1H, NH of amide); Anal. Calculated for C13H9-
Cl2NO4: C, 49.71; H, 2.89; N, 4.46; Found: C, 49.69; H, 2.92;
N, 4.42.
2.4.10. Compound 30
IR (ATR) cm1: 1242 and 1466 (CAO str. and OAH in plane
bending, phenol), 1636 (C‚O str., 30 amide), 3170 (CAH str.,
aromatic), 1551 (C‚C skeletal str., phenyl), 2972 (CAH str.,
alkane); 1H NMR (DMSO-d6): d 6.73–6.98 (m, 2H, aromatic),
3.55 (m, 2H, CH2), 2.08 (t, 3H, CH3); Anal. Calculated forbial evaluation and QSAR studies of gallic acid derivatives. Arabian
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Table 1 Physicochemical properties of synthesized gallic acid derivatives (1–33).
Comp. Mol. Formula M. Wt. m.p. (C) Rf Value* % Yield
1 C13H10ClNO4 279 178–180 0.52 66.5
2 C9H11NO4 197 105–107 0.49 65.0
3 C13H9NO7 291 151–153 0.50 78.5
4 C13H10O5 246 171–173 0.53 81.3
5 C13H16O5 252 183–185 0.63 71.4
6 C16H11NO5 297 258–260 0.72 76.2
7 C13H19NO4 253 96–98 0.69 60.5
8 C15H15NO4 273 168–170 0.57 62.8
9 C14H13NO4 259 221–223 0.83 69.8
10 C17H24O5 308 198–200 0.71 74.4
11 C13H12N2O4 260 165–167 0.67 83.0
12 C8H8O5 184 135–137 0.87 77.5
13 C19H15NO4 321 250–252 0.47 64.2
14 C14H12N2O6 304 156–158 0.55 80.4
15 C13H10N2O6 290 207–209 0.84 66.8
16 C13H9ClN2O6 324 191–193 0.77 70.3
17 C13H10N2O6 290 182–184 0.91 55.0
18 C15H13NO5 287 195–197 0.85 68.5
19 C14H12O5 260 234–236 0.73 73.2
20 C13H10N2O5 274 222–224 0.66 49.7
21 C14H11NO5 272 249–251 0.97 58.3
22 C9H10O5 198 242–244 0.82 67.4
23 C10H12O5 212 122–124 0.76 55.5
24 C12H16O5 240 134–136 0.53 76.4
25 C14H13NO5 275 208–210 0.48 64.0
26 C11H14O5 226 141–143 0.68 68.7
27 C13H10N2O6 290 187–189 0.91 76.7
28 C13H9Cl2NO4 314 194–196 0.88 75.3
29 C13H9Cl2NO4 314 233–235 0.81 56.5
30 C11H15NO4 225 121–123 0.61 67.7
31 C13H9ClN2O6 324 249–251 0.70 50.4
32 C13H11NO5 261 255–257 0.63 78.5
33 C17H13NO4 295 208–210 0.76 73.9
* TLC mobile phase: Benzene:Chloroform (7:3).
4 A. Khatkar et al.C11H15NO4: C, 58.66; H, 6.71; N, 6.22; Found: C, 58.70; H,
6.73; N, 6.25.
2.5. In vitro antimicrobial activity
2.5.1. Determination of minimum inhibitory concentration
The antimicrobial activity of the synthesized compounds was
tested against Gram-positive bacteria: S. aureus MTCC 2901,
Bacillus subtilis MTCC 2063, and Gram negative bacterium:
Escherichia coli MTCC 1652 and fungal strains: Candida albi-
cans MTCC 227 and Aspergillus niger MTCC 8189 using the
tube dilution method (Cappucino and Sherman, 1999). Dilu-
tions of test and standard compounds were prepared in double
strength nutrient broth––I.P. (bacteria) or Sabouraud dextrose
broth I.P. (fungi) (Pharmacopoeia of India, 2007). The sam-
ples were incubated at 37 C for 24 h (bacteria), at 25 C for
7 days (A. niger), and at 37 C for 48 h (C. albicans), and the
results were recorded in terms of minimum inhibitory concen-
tration (MIC).
2.5.2. Determination of minimum bactericidal/fungicidal
concentration
The minimum bactericidal concentration (MBC) and mini-
mum fungicidal concentration (MFC) were determined by
sub culturing 100 lL of culture from each tube (whichPlease cite this article in press as: Khatkar, A. et al., Synthesis, antimicro
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2013.11.01remained clear in the MIC determination) on fresh medium.
MBC and MFC values represent the lowest concentration of
compound that produces a 99.9% end point reduction
(Rodriguez-Arguelles et al., 2005).2.6. QSAR Studies
The structures of gallic derivatives were ﬁrst pre-optimized
with the Molecular Mechanics Force Field (MM+) procedure
included in Hyperchem 6.03 (Hyperchem 6.0, 1993) and the
resulting geometries were further reﬁned by means of the semi-
empirical method PM3 (Parametric Method-3). We chose a
gradient norm limit of 0.01 kcal/A˚ for the geometry optimiza-
tion. The lowest energy structure was used for each molecule
to calculate physicochemical properties using TSAR 3.3 soft-
ware for Windows (TSAR 3D Version 3.3, 2000). Further,
the regression analysis was performed using the SPSS software
package (SPSS for Windows, 1999).
The predictive powers of the equations were validated by
the leave one out (LOO) cross validation method (Agrawal
et al., 2006), where a model is built with N-1 compounds
and Nth compound is predicted. Each compound is left out
of the model derivation and predicted in turn. An indication
of the performance is obtained from the cross-validated r2
method which is deﬁned asbial evaluation and QSAR studies of gallic acid derivatives. Arabian
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Table 2 Antimicrobial activity (pMIC in lM/mL) of synthesized gallic acid derivatives against different microorganisms.
S. No. pMICec pMICsa pMICbs pMICan pMICca pMICab pMICaf pMICam
1 1.35 1.35 1.35 1.35 1.95 1.35 1.65 1.47
2 0.90 1.20 1.20 1.80 1.50 1.10 1.65 1.32
3 1.37 1.37 1.97 1.37 1.97 1.57 1.67 1.61
4 1.29 1.29 1.29 1.29 1.90 1.29 1.60 1.41
5 1.30 1.30 1.30 1.30 1.30 1.30 1.30 1.30
6 1.98 1.98 1.98 1.68 1.98 1.98 1.83 1.92
7 1.31 1.31 1.31 1.31 1.91 1.31 1.61 1.43
8 1.04 1.34 1.34 1.34 1.34 1.24 1.34 1.28
9 1.32 1.32 1.32 1.32 1.32 1.32 1.32 1.32
10 1.69 1.39 1.99 1.39 1.69 1.69 1.54 1.63
11 1.32 1.32 1.92 1.02 1.62 1.52 1.32 1.44
12 1.47 0.87 1.77 0.57 1.47 1.37 1.02 1.23
13 1.41 1.41 2.01 1.41 1.71 1.61 1.56 1.59
14 1.39 1.39 1.99 1.09 1.69 1.59 1.39 1.51
15 1.37 1.37 1.67 1.37 1.37 1.47 1.37 1.43
16 1.41 1.41 1.72 1.41 1.72 1.51 1.57 1.53
17 1.37 1.37 1.67 1.06 1.67 1.47 1.37 1.43
18 1.11 1.11 1.72 1.11 1.41 1.31 1.26 1.29
19 1.32 1.62 1.62 1.32 1.32 1.52 1.32 1.44
20 1.34 1.34 1.34 1.04 1.64 1.34 1.34 1.34
21 1.34 1.04 1.04 1.34 1.34 1.14 1.34 1.22
22 1.50 1.20 1.50 1.20 1.20 1.40 1.20 1.32
23 1.53 1.23 1.23 1.23 1.23 1.33 1.23 1.29
24 1.28 1.28 1.58 1.28 1.28 1.38 1.28 1.34
25 1.34 1.34 1.34 1.04 1.64 1.34 1.34 1.34
26 1.26 1.26 1.56 1.56 1.56 1.36 1.56 1.44
27 1.37 1.37 1.67 1.37 1.37 1.47 1.37 1.43
28 0.80 1.40 1.40 1.10 1.40 1.20 1.25 1.22
29 1.40 1.40 1.70 1.10 0.80 1.50 0.95 1.28
30 1.26 1.56 1.26 1.26 1.26 1.36 1.26 1.32
31 1.41 1.41 1.41 1.41 1.41 1.41 1.41 1.41
32 1.06 1.36 1.36 1.06 1.36 1.26 1.21 1.24
33 1.71 2.01 2.01 1.71 1.71 1.91 1.71 1.83
S.D. 0.22 0.21 0.28 0.23 0.27 0.19 0.20 0.16
Std. 2.61* 2.61* 2.61* 2.64** 2.64** – – –
S.D. = Standard deviation; Std. = Standard.
* Norﬂoxacin.
** Fluconazole.
Synthesis, antimicrobial evaluation and QSAR studies of gallic acid derivatives 5q2 ¼ 1 RðYpredicted  YactualÞ2=RðYactual  YmeanÞ2
where, Ypredicted, Yactual and Ymean are predicted, actual and
mean values of target property (pMIC), respectively. R(Ypre-
dicted  Yactual)2 is the predictive residual error sum of squares.
3. Results and discussion
3.1. Chemistry
Gallic acid derivatives (1–33) were synthesized as outlined in
Scheme 1. The physicochemical properties of the synthesized
compounds are presented in Table 1. The structures of all
the newly synthesized compounds were conﬁrmed by the IR,
1H NMR and elemental analysis which were in full agreement
with their structures.
3.2. In vitro antimicrobial activity
The synthesized gallic acid derivatives were evaluated for their
in vitro antibacterial activity against S. aureus, B. subtilis,
E. coli and antifungal activity against C. albicans and A. nigerPlease cite this article in press as: Khatkar, A. et al., Synthesis, antimicro
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2013.11.01by the tube dilution method. From the recorded pMIC values
(Table 2), it was observed that compound 6 was found to be
most active against C. albicans and E. coli, having pMICca
and pMICec value 1.98 lM/mL. Compound 33 was found to
be most active against S. aureus having pMICsa value
2.01 lM/mL. The compound 2 was found to be most active
against A. niger having pMICan value 1.80 lM/mL and com-
pounds 13 and 33 were found to be most potent against B. sub-
tilis having pMICbs value 2.01 lM/mL.
In general, the results of MBC/MFC studies (Table 3)
revealed that the synthesized compounds were bacteriostatic
and fungistatic in action as their MFC and MBC values were
3-fold higher than their MIC values (a drug is considered to be
bacteriostatic/fungistatic when its MFC and MBC values are
3-fold higher than its MIC value) (Rodriguez-Arguelles
et al., 2005).
3.3. Structure–activity relationship
From the antimicrobial activity results of the synthesized gallic
acid derivatives, the following structure–activity relationship
can be withdrawn:bial evaluation and QSAR studies of gallic acid derivatives. Arabian
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Table 3 Minimum bactericidal/fungicidal (MBC/MFC in lM/mL) of synthesized gallic acid derivatives against different
microorganisms.
S. No. E. coli S. aureus B. subtilis A. niger C. albicans
1 >0.18 >0.18 >0.18 >0.18 >0.18
2 >0.25 >0.25 >0.25 >0.25 >0.25
3 >0.17 >0.17 >0.17 >0.17 >0.17
4 >0.20 >0.20 >0.20 >0.20 >0.20
5 >0.20 >0.20 >0.20 >0.20 >0.20
6 >0.17 >0.17 >0.17 >0.17 >0.17
7 >0.20 >0.20 >0.20 >0.20 >0.20
8 >0.18 >0.18 >0.18 >0.18 >0.18
9 >0.19 >0.19 >0.19 >0.19 >0.19
10 >0.16 >0.16 >0.16 >0.16 >0.16
11 >0.19 >0.19 >0.19 >0.19 >0.19
12 >0.27 >0.27 >0.27 >0.27 >0.27
13 >0.16 >0.16 >0.16 >0.16 >0.16
14 >0.16 >0.16 >0.16 >0.16 >0.16
15 >0.17 >0.17 >0.17 >0.17 >0.17
16 >0.15 >0.15 >0.15 >0.15 >0.15
17 >0.17 >0.17 >0.17 >0.17 >0.17
18 >0.17 >0.17 >0.17 >0.17 >0.17
19 >0.19 >0.19 >0.19 >0.19 >0.19
20 >0.18 >0.18 >0.18 >0.18 >0.18
21 >0.18 >0.18 >0.18 >0.18 >0.18
22 >0.25 >0.25 >0.25 >0.25 >0.25
23 >0.24 >0.24 >0.24 >0.24 >0.24
24 >0.21 >0.21 >0.21 >0.21 >0.21
25 >0.18 >0.18 >0.18 >0.18 >0.18
26 >0.22 >0.22 >0.22 >0.22 >0.22
27 >0.17 >0.17 >0.17 >0.17 >0.17
28 >0.16 >0.16 >0.16 >0.16 >0.16
29 >0.16 >0.16 >0.16 >0.16 >0.16
30 >0.22 >0.22 >0.22 >0.22 >0.22
31 >0.15 >0.15 >0.15 >0.15 >0.15
32 >0.19 >0.19 >0.19 >0.19 >0.19
33 >0.17 >0.17 >0.17 >0.17 >0.17
Std. 0.019* 0.019* 0.019* 0.040** 0.040**
* Norﬂoxacin.
** Fluconazole.
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Figure 1 SAR of antimicrobial activity of synthesized gallic acid derivatives.
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Synthesis, antimicrobial evaluation and QSAR studies of gallic acid derivatives 7 Esters and amides of gallic acid were more potent antimi-
crobial agents than anilides. The high antimicrobial activity
of esters is also supported by results of Mahiwal et al.
(2012).
 In case of antimicrobial activity of gallic acid derivatives
against E. coli and C. albicans, quinolin-8-yl 3,4,5-trihy-
droxybenzoate (6) was found to be the most potent antimi-
crobial agent, which indicated that esters having bulky
aromatic group will be more potent antimicrobial agents
against E. coli and C. albicans. This fact is supported by
ﬁndings of Sarova et al. (2011).
 In case of antibacterial activity of gallic acid derivatives
against S. aureus, 3,4,5-trihydroxy-N-(naphthalen-2-yl)
benzamide (33) having bicyclic aromatic ring (naphthalene)
was found to be the most potent antibacterial agent.
 In case of antibacterial activity of gallic acid derivatives
against B. subtilis, 3,4,5-trihydroxy-N,N-diphenylbenza-
mide (13) and 3,4,5-trihydroxy-N-(naphthalen-2-yl) benz-
amide (33) having two phenyl substituents and bicyclic
aromatic ring (naphthalene), respectively were found to be
the most potent antibacterial agents, which indicated that
amides having bulky aromatic group will be more potent
antibacterial agents against B. subtilis. These results are in
accordance with the results of Mahiwal et al. (2012).
 Results of antifungal activity against A. niger indicated that
3,4,5-trihydroxy-N,N-dimethylbenzamide (2) was found to
be the most potent one and the activity decreased uponTable 4 Values of selected parameters used in QSAR studies of sy
Comp. Cos E Log P MR 0v 0vv
1 4.29 2.47 69.20 13.99 10.4
2 21.63 0.52 49.51 10.88 7.8
3 22.84 2.56 69.77 15.57 10.3
4 15.04 2.61 62.45 13.12 9.2
5 12.78 2.51 63.68 13.12 9.9
6 26.82 2.69 76.37 15.69 11.2
7 6.51 2.27 67.69 13.54 10.4
8 0.47 2.89 74.48 14.86 11.1
9 0.80 2.42 69.44 13.99 10.2
10 11.04 3.97 81.85 16.44 13.2
11 2.05 1.17 69.10 13.99 9.7
12 18.10 0.92 42.67 10.01 6.8
13 23.22 3.88 89.07 17.10 12.6
14 8.64 2.38 76.76 16.44 11.4
15 10.36 1.91 71.72 15.57 10.4
16 12.20 2.43 76.52 16.44 11.6
17 13.18 1.91 71.72 15.57 10.4
18 1.55 1.95 73.96 15.57 11.1
19 14.52 2.70 67.28 13.83 9.9
20 6.44 1.09 67.27 14.70 10.0
21 6.44 1.09 67.27 14.70 10.0
22 14.61 1.27 47.42 10.72 7.5
23 8.31 1.68 51.83 11.59 8.3
24 10.44 2.46 61.09 13.00 9.8
25 0.64 1.70 70.86 14.70 10.6
26 10.69 2.14 56.41 12.29 9.1
27 2.68 1.91 71.72 15.57 10.4
28 2.47 2.99 74.00 14.86 11.5
29 3.09 2.99 74.00 14.86 11.5
30 17.51 1.21 59.01 12.29 9.2
31 5.53 2.43 76.52 16.44 11.6
32 1.16 1.82 67.15 13.99 9.7
33 4.68 2.96 80.85 15.69 11.4
Please cite this article in press as: Khatkar, A. et al., Synthesis, antimicro
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2013.11.01increase in carbon chain length as evidenced by low anti-
fungal activity of 3,4,5-trihydroxy-N,N-diethylbenzamide
(30).
 The anilide formation does not improve the antimicrobial
proﬁle of 2-amino benzoic acid as none of the synthesized
anilides were found to be active.
 From the abovementioned antimicrobial activity results, it
can be concluded that different structural requirements
are necessary for different gallic acid derivatives to become
active against different microbial targets. This is in accor-
dance with the results obtained by Sortino et al. (2007).
The above mentioned ﬁndings are summarized in Fig. 1.3.4. QSAR Studies
In the present study, we have performed the quantitative
structure–activity relationship study by conventional Hansch’s
analysis using the linear free energy relationship model
(LFER) (Hansch and Fujita, 1964). In this approach, struc-
tural features of drug molecules are quantiﬁed in terms of dif-
ferent parameters and these structural features are correlated
to quantiﬁed biological activity through equation using regres-
sion analysis. Biological activity data determined as MIC val-
ues were ﬁrst transformed into pMIC values (i.e. log MIC,
Table 2) and used as dependent variable in the QSAR study.nthesized gallic acid derivatives.
J Nu. E LUMO HOMO l
1 1.63 16570.80 0.58 8.89 1.38
5 2.29 11657.10 0.37 9.36 4.45
9 1.63 19586.30 1.22 9.63 7.38
0 1.63 15381.10 0.80 9.43 1.90
3 1.63 17232.10 0.53 9.27 0.47
2 1.42 20727.80 0.75 9.08 1.80
4 2.08 16624.40 0.50 9.38 3.84
4 1.69 18580.00 0.62 8.58 4.21
1 1.63 16694.40 0.64 8.64 3.92
4 1.76 25766.80 0.72 9.38 2.49
9 1.70 17053.00 0.43 8.52 2.33
1 2.23 10089.70 0.59 9.31 3.45
3 1.55 24815.90 0.39 8.80 3.27
0 1.71 21698.10 1.02 9.39 7.77
8 1.63 19409.60 1.17 9.52 7.76
0 1.70 21335.40 1.33 9.45 5.36
8 1.62 19594.00 1.04 9.53 5.34
5 1.86 20732.20 0.32 9.18 3.68
1 1.58 16856.20 0.80 9.44 2.66
7 1.66 18028.80 0.79 9.27 4.18
7 1.66 18028.80 0.79 9.27 4.18
2 2.22 11420.10 0.55 9.14 3.16
9 2.25 12979.60 0.72 9.38 2.38
0 2.16 15595.20 0.74 9.39 2.50
2 1.62 18266.40 0.47 8.44 2.85
0 2.21 14508.10 0.75 9.40 2.81
8 1.75 20285.30 1.11 9.36 3.81
3 1.64 18145.80 0.82 8.99 5.86
3 1.68 18450.90 0.77 9.11 2.57
7 2.36 14837.40 0.12 9.17 3.33
0 1.66 21290.00 1.06 9.47 6.63
0 1.63 16868.50 0.77 8.47 3.27
5 1.33 19999.00 0.70 8.47 3.80
bial evaluation and QSAR studies of gallic acid derivatives. Arabian
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(independent variables) like log of octanol–water partition
coefﬁcient (log P), molar refractivity (MR), Kier’s molecular
connectivity (0v, 0vv, 1v, 1vv, 2v, 2vv) and shape (j1, j1, j2,
j3) topological indices, Randic topological index (R), Balaban
topological index (J), Wiener topological index (W), Total
energy (Te), energies of highest occupied molecular orbital
(HOMO) and lowest unoccupied molecular orbital (LUMO),
dipole moment () and electronic energy (Ele. E) (Hansch and
Fujita, 1964; Kier and Hall, 1976; Randic, 1975, 1993;
Balaban, 1982; Wiener, 1947) were calculated for gallic acid
derivatives and values of selected descriptors are presented in
Table 4.
Our previous studies in the ﬁeld of QSAR studies (Narang
et al., 2012a,b; Judge et al., 2012a,b; Kumar et al., 2009, 2010),
indicated that the multi-target QSAR (mt-QSAR) models are
better than one-target QSAR (ot-QSAR) models in describing
the antimicrobial activity. So, in the present study we have
developed multi-target QSAR models to describe the antimi-
crobial activity of synthesized gallic acid derivatives.
According to the ot-QSAR models, one should use ﬁve dif-
ferent equations with different errors to predict the activity of
a new compound against ﬁve microbial species. However, very
recently the interest has been increased in the development of
multi-target QSAR (mt-QSAR) models. As opposed to ot-
QSAR, the mt-QSAR model is a single equation that considers
the nature of molecular descriptors which are common and
essential for describing the antibacterial and antifungal activity
(Gonzalez-Diaz et al., 2008, 2007; Cruz-Monteagudo et al.,
2007; Gonzalez-Diaz and Prado-Prado, 2008).
In the present study, we attempted to develop three differ-
ent types of mt-QSAR models viz. the mt-QSAR model for
describing antibacterial activity of synthesized compounds
against S. aureus, B. subtilis and E. coli, the mt-QSAR model
for describing antifungal activity against C. albicans and A.
niger as well as a common mt-QSAR model for describing
the antimicrobial (overall antibacterial and antifungal) activity
of synthesized gallic acid derivatives by calculating their aver-
age antibacterial activity, antifungal activity and antimicrobial
activity values which are presented in Table 2.
In the present study, a dataset of 33 gallic acid derivatives
(1–33) was used for linear regression model generation. The
standard drugs norﬂoxacin and ﬂuconazole were not included
in model generation because of dissimilarity in structure with
synthesized compounds. Different outliers were identiﬁed in
case of antibacterial, antifungal and antimicrobial activities
and the models have been developed after removal of theTable 5 Correlation matrix for the antibacterial activity of synthes
pMICab Cos E Log P MR
0v
pMICab 1.000
Cos E 0.326 1.000
Log P 0.511 0.478 1.000
MR 0.711 0.090 0.582 1.000
0v 0.724 0.086 0.436 0.936 1.000
j1 0.714 0.098 0.422 0.915 0.987
J 0.334 0.081 0.314 0.659 0.658
Nu. E 0.785 0.186 0.587 0.937 0.942
LUMO 0.320 0.068 0.078 0.218 0.499
HOMO 0.131 0.427 0.111 0.158 0.062
l 0.375 0.133 0.101 0.352 0.587
Please cite this article in press as: Khatkar, A. et al., Synthesis, antimicro
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2013.11.01outliers (compound numbers in brackets) i.e. antibacterial (2,
6, 8, 12, 18, 21, 22, 28, 32 and 33), antifungal (1, 5, 6, 7, 12,
19, 22, 23, 27, 29, 30 and 33) and antimicrobial (3, 6, 8, 18,
21, 26, 28, 29, 32 and 33). In multivariate statistics, it is com-
mon to deﬁne three types of outliers (Furusjo et al., 2006).
1. X/Y relation outliers are substances for which the relation-
ship between the descriptors (X variables) and the depen-
dent variables (Y variables) is not the same as in the (rest
of the) training data.
2. X outliers are substances whose molecular descriptors do
not lie in the same range as the (rest of the) training data.
3. Y outliers are only deﬁned for training or test samples.
They are substances for which the reference value of
response is invalid.
As there was no difference in the activity (Table 2) as well
as the molecular descriptor range (Table 4) of these outliers
when compared to other gallic acid derivatives, these outliers
belong to the category of Y outliers (Substances for which
the reference value of response is invalid).
In order to develop mt-QSAR models, initially we calcu-
lated the average antibacterial, antifungal and antimicrobial
activity values of gallic acid derivatives which are presented
in Table 2. These average antibacterial activity values were
correlated with the molecular descriptors of synthesized com-
pounds (Table 5). In general, high colinearity (r> 0.5) was
observed between different parameters. The high interrelation-
ship was observed between topological parameters, zero order
molecular connectivity index (0v) and Kier’s ﬁrst order shape
index (j1) (r= 0.987) and low interrelationship was observed
for electronic parameters, energy of highest occupied molecu-
lar orbital (HOMO) and nuclear energy (Nu. E) (r= 0.059).
From the correlation matrix (Table 5), it was observed that
electronic parameter, nuclear energy (Nu. E) was found to be
dominating descriptor for antibacterial activity of the synthe-
sized compounds (Eq. (1)).
3.4.1. LR-mt-QSAR model for antibacterial activity
pMICab ¼ 0:000028 Nu:Eþ 0:915 ð1Þ
n= 23 r= 0.785 q2 = 0.559 s= 0.072 F= 33.80
Here and thereafter, n – number of data points, r – correla-
tion coefﬁcient, q2 – cross validated r2 obtained by the leave
one out method, s – standard error of the estimate and F –
Fischer statistics.ized gallic acid derivatives.
j1 J Nu. E LUMO HOMO l
1.000
0.559 1.000
0.933 0.544 1.000
0.505 0.343 0.330 1.000
0.126 0.187 0.059 0.641 1.000
0.630 0.196 0.405 0.669 0.409 1.000
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Table 6 Comparison of observed and predicted antimicrobial activity obtained by mt-QSAR models.
Comp. pMICab pMICaf pMICam
Obs Pre Res Obs Pre Res Obs Pre Res
1 1.35 1.38 0.03 1.65 1.37 0.28 1.47 1.38 0.09
2 1.10 1.24 0.14 1.65 1.59 0.06 1.32 1.28 0.04
3 1.57 1.47 0.10 1.67 1.61 0.06 1.61 1.45 0.16
4 1.29 1.35 0.06 1.60 1.51 0.09 1.41 1.36 0.05
5 1.30 1.40 0.10 1.30 1.48 0.18 1.30 1.40 0.10
6 1.98 1.50 0.48 1.83 1.66 0.17 1.92 1.47 0.45
7 1.31 1.39 0.08 1.61 1.40 0.21 1.43 1.38 0.05
8 1.24 1.44 0.20 1.34 1.33 0.01 1.28 1.43 0.15
9 1.32 1.39 0.07 1.32 1.33 0.01 1.32 1.39 0.07
10 1.69 1.64 0.05 1.54 1.46 0.08 1.63 1.58 0.05
11 1.52 1.40 0.12 1.32 1.30 0.02 1.44 1.39 0.05
12 1.37 1.20 0.17 1.02 1.55 0.53 1.23 1.25 0.02
13 1.61 1.62 0.01 1.56 1.61 0.05 1.59 1.56 0.03
14 1.59 1.53 0.06 1.39 1.43 0.04 1.51 1.49 0.02
15 1.47 1.46 0.01 1.37 1.45 0.08 1.43 1.44 0.01
16 1.51 1.52 0.01 1.57 1.47 0.10 1.53 1.48 0.05
17 1.47 1.47 0.00 1.37 1.49 0.12 1.43 1.45 0.02
18 1.31 1.50 0.19 1.26 1.34 0.08 1.29 1.47 0.18
19 1.52 1.39 0.13 1.32 1.50 0.18 1.44 1.39 0.05
20 1.34 1.43 0.09 1.34 1.24 0.10 1.34 1.41 0.07
21 1.14 1.43 0.29 1.34 1.24 0.10 1.22 1.41 0.19
22 1.40 1.24 0.16 1.20 1.50 0.30 1.32 1.27 0.05
23 1.33 1.28 0.05 1.23 1.42 0.19 1.29 1.31 0.02
24 1.38 1.36 0.02 1.28 1.45 0.17 1.34 1.36 0.02
25 1.34 1.43 0.09 1.34 1.33 0.01 1.34 1.42 0.08
26 1.36 1.33 0.03 1.56 1.45 0.11 1.44 1.34 0.10
27 1.47 1.49 0.02 1.37 1.35 0.02 1.43 1.46 0.03
28 1.20 1.43 0.23 1.25 1.35 0.10 1.22 1.42 0.20
29 1.50 1.44 0.06 0.95 1.36 0.41 1.28 1.42 0.14
30 1.36 1.33 0.03 1.26 1.54 0.28 1.32 1.35 0.03
31 1.41 1.52 0.11 1.41 1.39 0.02 1.41 1.48 0.07
32 1.26 1.39 0.13 1.21 1.34 0.13 1.24 1.39 0.15
33 1.91 1.48 0.43 1.71 1.38 0.33 1.83 1.45 0.38
Observed pMICab
1.71.61.51.41.31.2
Pr
ed
ic
te
d 
pM
IC
ab
1.7
1.6
1.5
1.4
1.3
1.2
Figure 2 Plot of observed pMICab against predicted pMICab
obtained by Eq. (1).
Synthesis, antimicrobial evaluation and QSAR studies of gallic acid derivatives 9The developed QSAR model for antibacterial activity (Eq.
(1)) indicated that there is a positive correlation between
nuclear energy and antibacterial activity of the synthesized
compounds. This means that antibacterial activity of synthe-
sized gallic acid derivatives will increase with increase in their
Nu. E values and vice versa, which is evidenced by low anti-
bacterial activity value of compound 2 (pMICab = 1.10 lM/
mL, Table 2) having low Nu. E value (11657.10, Table 4).
The developed QSAR model (Eq. (1)) was cross validated
by q2 value (q2 = 0.559) obtained by the leave one out
(LOO) method. The value of q2 more than 0.5 indicated that
the model developed is a valid one (Golbraikh and Tropsha,
2002). As the observed and predicted antibacterial activity val-
ues are close to each other (Table 6), the mt-QSAR model for
antibacterial activity (Eq. (1)) is a valid one. The plot of pre-
dicted pMICab against observed pMICab (Fig. 2) also favors
the developed model expressed by Eq. (1).
In case of antifungal activity, electronic parameter, cosmic
total energy (Cos E) was found most dominant in expressing
antifungal activity of the synthesized compounds. So, the
QSAR model for antifungal activity (Eq. (2)) was developed
using Cos E
3.4.2. LR-mt-QSAR model for antifungal activity
pMICaf ¼ 0:0125 Cos Eþ 1:321 ð2ÞPlease cite this article in press as: Khatkar, A. et al., Synthesis, antimicro
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2013.11.01n= 21 r= 0.786 q2 = 0.539 s= 0.089 F= 3.78
As in case of antibacterial activity, antifungal activity of the
synthesized compounds is also positively correlated with theirbial evaluation and QSAR studies of gallic acid derivatives. Arabian
4
10 A. Khatkar et al.Cos E values which means that antifungal activity of the syn-
thesized compounds will increase with increase in their Cos E
values (Tables 2 and 5).
The validity and predictability of the QSAR model for anti-
fungal activity i.e. Eq. (2) was cross validated by q2 value
(q2 = 0.539) obtained by the leave one out (LOO) method
and by comparison of the observed and predicted antifungal
activity values (Table 6), which indicated that the mt-QSAR
model for antifungal activity (Eq. (2)) is a valid one.
Electronic parameter, nuclear energy (Nu. E) was found to
be most effective in describing antimicrobial activity of the
synthesized compounds (Eq. (3)).
3.4.3. LR-mt-QSAR model for antimicrobial activity
pMICam ¼ 0:0000211 Nu: Eþ 1:033 ð3Þ
n= 23 r= 0.848 q2 = 0.671 s= 0.054 F= 53.57
As in case of antibacterial activity, antimicrobial activity of
the synthesized compounds is positively correlated with
nuclear energy (Nu. E) which means that antimicrobial activity
of the synthesized compounds will increase with increase in
their Nu. E values (Tables 2 and 5).
The validity of the QSAR model for antimicrobial activity
(Eq. (3)) is indicated by their high q2 value (0.671) as well as
the low residual values (Table 6). Further, the plot of observed
pMICam vs residual pMICam (Fig. 3) indicated that there was
no systemic error in model development as the propagation of
error was observed on both sides of zero (Kumar et al., 2007).
It is important to note a fact that the high residual values
observed in case of outliers justify their removal before devel-
opment of QSAR models.
It was observed from mt-QSAR models [Eq. (1–3)] that the
antibacterial, antifungal and the overall antimicrobial activi-
ties of the synthesized gallic acid derivatives were governed
by electronic parameters, nuclear energy (Nu. E) and cosmic
total energy (Cos E).
Generally for QSAR studies, the biological activities of
compounds should span 2–3 orders of magnitude. But in the
present study the range of antimicrobial activities of theObserved pMICam
1.71.61.51.41.31.2
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Figure 3 Plot of observed pMICam against residual pMICam
obtained by Eq. (3).
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Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2013.11.01synthesized compounds is within one order of magnitude. This
is in accordance with results suggested by Bajaj et al. (2005)
who stated that the reliability of the QSAR model lies in its
predictive ability even though the activity data are in the nar-
row range. When biological activity data lies in the narrow
range, the presence of minimum standard deviation of the bio-
logical activity justiﬁes its use in QSAR studies (Narasimhan
et al., 2007). The minimum standard deviation (Table 2)
observed in the antimicrobial activity data justiﬁes its use in
QSAR studies.4. Conclusion
A series of gallic acid derivatives (1–33) was synthesized and
evaluated in vitro for its antimicrobial activity by the tube dilu-
tion method. Results of antimicrobial screening indicated that
esters and amides of gallic acid were more potent than anilides
and compound 6 was the most active antimicrobial agent
(pMICam = 1.92 lM/mL). Results of MBC/MFC studies indi-
cated that the synthesized compounds were bacteriostatic and
fungistatic in action. The results of QSAR studies demon-
strated that antibacterial, antifungal and overall antimicrobial
activities of synthesized gallic acid derivatives were governed
by the electronic parameters, cosmic total energy (Cos E)
and nuclear energy (Nu. E.).References
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